Current NDC auxiliary source row compounder:4411
This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.
Complete normalized row#
- Record Source
- ndc_compounder_zip
- Product Ndc Raw
- 83298-100
- Product Ndc
- 83298-100
- Product Ndc Digits
- 83298100
- Product Type Name
- HUMAN COMPOUNDED DRUG
- Proprietary Name
- Miglustat Oral Suspension
- Proprietary Name Suffix
- Nonproprietary Name
- Miglustat Oral Suspension
- Dosage Form Name
- SUSPENSION
- Route Name
- ORAL
- Marketing Category Name
- OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
- Labeler Name
- Mark Cuban Cost Plus Manufacturing and Compounding LLC
- Establishment Name
- Mark Cuban Cost Plus Manufacturing and Compounding LLC
- Establishment Fei
- Substance Name
- MIGLUSTAT
- Active Ingredients Info
- 100 mg/150 mL
- History Active Ingredients Raw
- MIGLUSTAT
- History Active Ingredients Info Raw
- 100 mg/150 mL
- History Dosage Raw
- SUSPENSION
- Dea Schedule
- Package Ndc Raw
- 83298-100-30
- Package Ndc
- 83298-100-30
- Package Ndc Digits
- 8329810030
- Package Ndc11
- 83298010030
- Package Description
- 150 mL in 1 BOTTLE (83298-100-30)
- Reporting Period Raw
- 2024-2
- Reporting Period
- 2024-2
- Normalization Status
- valid
- Source Archive
- compounders_ndc_directory.zip
- Source File
- compounders_ndc_directory.txt
- Source Date
- 2026-09-18
- Source Last Modified
- Fri, 18 Sep 2026 15:17:23 GMT
- Source Archive Sha256
- 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
- Source Member Sha256
- f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
- Source Record Id
- compounder:4411
- Source Row Number
- 4411
- Source Row Hash
- 68e678077aa519466f3a5725d5b16f04ef2411529b98b75e93a73084028119f6
- Import Run Id
- 20261119T172627Z
- Loaded At
- 2026-11-19 17:42:45
Exact raw FDA source fields#
{
"ROUTENAME": "ORAL",
"PRODUCTNDC": "83298-100",
"DEASCHEDULE": "",
"LABELERNAME": "Mark Cuban Cost Plus Manufacturing and Compounding LLC",
"SUBSTANCENAME": "MIGLUSTAT",
"DOSAGEFORMNAME": "SUSPENSION",
"NDCPACKAGECODE": "83298-100-30",
"PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
"PROPRIETARYNAME": "Miglustat Oral Suspension",
"REPORTINGPERIOD": "2024-2",
"NONPROPRIETARYNAME": "Miglustat Oral Suspension",
"PACKAGEDESCRIPTION": "150 mL in 1 BOTTLE (83298-100-30) ",
"ACTIVEINGREDIENTSINFO": "100 mg/150 mL",
"MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
"PROPRIETARYNAMESUFFIX": ""
}Normalization notes#
[]Current status projection#
- Dataset
- compounder
- Record Source
- ndc_compounder_zip
- Source Record Id
- compounder:4411
- Source Row Number
- 4411
- Status Scope
- package
- Lookup Ndc
- 83298-100-30
- Lookup Ndc Digits
- 8329810030
- Product Ndc
- 83298-100
- Product Ndc Digits
- 83298100
- Package Ndc
- 83298-100-30
- Package Ndc Digits
- 8329810030
- Package Ndc11
- 83298010030
- Product Id
- Status Code
- COMPOUNDER
- Status Label
- Outsourcing facility compounded drug report
- Reporting Period Raw
- 2024-2
- Reporting Period
- 2024-2
- Source Table
- fda_ndc_aux_compounder
- Source File
- compounders_ndc_directory.txt
- Source Date
- 2026-09-18
- Source Row Hash
- 68e678077aa519466f3a5725d5b16f04ef2411529b98b75e93a73084028119f6
- Import Run Id
- 20261119T172627Z
- Loaded At
- 2026-11-19 17:42:45